PsyPost on MSN
“Major problem”: Ketamine fails to outperform placebo for treating severe depression in new clinical trial
A new clinical trial has found that adding repeated intravenous ketamine infusions to standard care for hospitalized patients ...
Liability Risks of Ambient Clinical Workflows With Artificial Intelligence for Clinicians, Hospitals, and Manufacturers This single-center randomized clinical trial was conducted at its outpatient ...
“Well, we don’t have as much evidence as we would like on steroid use during pregnancy,” the obstetrician warned my co-author, Natalia Emanuel, as she wrote a prescription for inhaled corticosteroids ...
Long-Term Follow-Up of the Prospective Randomized AATT Study (Autologous or Allogeneic Transplantation in Patients With Peripheral T-Cell Lymphoma) Between March 19, 2019, and February 13, 2023, 41 ...
Chronic low back pain (CLBP) affects over half a billion people worldwide. Current pharmacologic treatments offer limited efficacy and carry substantial risks, warranting the development of safe and ...
VIENNA — Tirzepatide was associated with improvements in body weight and body composition, and with lower insulin doses, in the first-ever randomized controlled trial (RCT) of the drug in people with ...
News-Medical.Net on MSN
GeneSight test-guided treatment leads to faster remission and response in patients with depression
Myriad Genetics, Inc., a leader in molecular diagnostic testing and precision medicine, today announced a post-hoc analysis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback